Skip to main content
Erschienen in: Supportive Care in Cancer 8/2005

01.08.2005 | Original Article

Use of distress and depression thermometers to measure psychosocial morbidity among southern European cancer patients

verfasst von: Francisco Gil, Luigi Grassi, Luzia Travado, Michele Tomamichel, Juan Ramón Gonzalez, The SEPOS Group

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2005

Einloggen, um Zugang zu erhalten

Abstract

Goals of work

Recent literature has indicated the need for rapid evaluation of psychosocial issues secondary to cancer. Because of the problems of routine use of psychometric instruments, short instruments such as visual analogue scales or one-item 0–10 scales have been developed as valid assessment alternatives.

Patients and methods

A study was conducted to examine the role of two 0–10 scales in measuring emotional stress (distress thermometer, DT) and depressed mood (mood thermometer, MT), respectively, in a multicenter study carried out in southern European countries (Italy, Portugal, Spain, and Switzerland). A convenience sample of 312 cancer outpatients completed the DT and MT and the Hospital Anxiety Depression Scale (HADS).

Main results

DT was more significantly associated HADS anxiety than HADS depression while MT was related both to HADS anxiety and depression. The correlation of MT with HADS was higher than DT. A cutoff point >4 on the DT maximized sensitivity (65%) and specificity (79%) for general psychosocial morbidity while a cutoff >5 identified more severe “caseness” (sensitivity=70%; specificity=73%). On the MT, sensitivity and specificity for general psychosocial morbidity were 85% and 72% by using the cutoff score >3. A score >4 on the MT was associated with a sensitivity of 78% and a specificity of 77% in detecting more severe caseness.

Conclusions

Two simple instruments, the DT and the MT, were found to have acceptable levels of sensitivity and specificity in detecting psychosocial morbidity. Compared to the HADS, however, the mood MT performed better than the DT.
Literatur
1.
Zurück zum Zitat van’t Spijker A, Trijsburg RW, Duivenvoorden HJ (1997) Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 59:280–293PubMed van’t Spijker A, Trijsburg RW, Duivenvoorden HJ (1997) Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 59:280–293PubMed
2.
Zurück zum Zitat Sollner W, DeVries A, Steixner E, Lukas P, Sprinzl G, Rumpold G, Maislinger S (2001) How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer 84:179–185CrossRefPubMed Sollner W, DeVries A, Steixner E, Lukas P, Sprinzl G, Rumpold G, Maislinger S (2001) How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer 84:179–185CrossRefPubMed
3.
Zurück zum Zitat Fallowfield L, Ratcliffe D, Jenkins V, Saul J (2001) Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 84:1011–1015 Fallowfield L, Ratcliffe D, Jenkins V, Saul J (2001) Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 84:1011–1015
4.
Zurück zum Zitat Moorey S, Greer S, Watson M, Gorman C, Rowden L, Tunmore R, Robertson B, Bliss J (1991) The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry 158:255–259PubMed Moorey S, Greer S, Watson M, Gorman C, Rowden L, Tunmore R, Robertson B, Bliss J (1991) The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry 158:255–259PubMed
5.
Zurück zum Zitat Carroll B, Kathol R, Noyes R, Wald TG, Clamon GH (1993) Screening for depression and anxiety in cancer patients using the hospital anxiety and depression scale. Gen Hosp Psychiatry 15:69–74 Carroll B, Kathol R, Noyes R, Wald TG, Clamon GH (1993) Screening for depression and anxiety in cancer patients using the hospital anxiety and depression scale. Gen Hosp Psychiatry 15:69–74
6.
Zurück zum Zitat Smith AB, Selby PJ, Velikova G, Stark D, Wright EP, Gould A, Cull A (2002) Factor analysis of the hospital anxiety and depression scale from a large cancer population. Psychol Psychother 75:165–176CrossRef Smith AB, Selby PJ, Velikova G, Stark D, Wright EP, Gould A, Cull A (2002) Factor analysis of the hospital anxiety and depression scale from a large cancer population. Psychol Psychother 75:165–176CrossRef
7.
Zurück zum Zitat Zabora J, Brintzenhofe-Szoc K, Jacobsen P, Curbow B, Piantadosi S, Hooker C, Owens A, Derogatis L (2001) A new psychosocial screening instrument for use with cancer patients. Psychosomatics 42 241–246 Zabora J, Brintzenhofe-Szoc K, Jacobsen P, Curbow B, Piantadosi S, Hooker C, Owens A, Derogatis L (2001) A new psychosocial screening instrument for use with cancer patients. Psychosomatics 42 241–246
8.
Zurück zum Zitat Baker F, Denniston M, Zabora J, Polland A, Dudley WN (2002) A POMS short form for cancer patients: psychometric and structural evaluation. Psychooncology 11:273–281 Baker F, Denniston M, Zabora J, Polland A, Dudley WN (2002) A POMS short form for cancer patients: psychometric and structural evaluation. Psychooncology 11:273–281
9.
Zurück zum Zitat Passik SD, Kirsh KL, Donaghy KB, Theobald DE, Lundberg JC, Holtsclaw E, Dugan WM Jr (2001) An attempt to employ the Zung self-rating depression scale as a “lab test” to trigger follow-up in ambulatory oncology clinics: criterion validity and detection. J Pain Symptom Manage 21:273–281 Passik SD, Kirsh KL, Donaghy KB, Theobald DE, Lundberg JC, Holtsclaw E, Dugan WM Jr (2001) An attempt to employ the Zung self-rating depression scale as a “lab test” to trigger follow-up in ambulatory oncology clinics: criterion validity and detection. J Pain Symptom Manage 21:273–281
10.
Zurück zum Zitat Liang LP, Dunn SM, Gorman A, Stuart-Harris R (1990) Identifying priorities of psychosocial need in cancer patients. Br J Cancer 62:1000–1003 Liang LP, Dunn SM, Gorman A, Stuart-Harris R (1990) Identifying priorities of psychosocial need in cancer patients. Br J Cancer 62:1000–1003
11.
Zurück zum Zitat Maguire P (2002) Improving the recognition of concerns and affective disorders in cancer patients. Ann Oncol 13(Suppl 4):177–181 Maguire P (2002) Improving the recognition of concerns and affective disorders in cancer patients. Ann Oncol 13(Suppl 4):177–181
12.
13.
Zurück zum Zitat Holland J (2000) An algorithm for rapid assessment and referral of distressed patients. In: Perry CM (ed) American society of clinical oncology educational book. ASCO, Alexandria, pp 129–138 Holland J (2000) An algorithm for rapid assessment and referral of distressed patients. In: Perry CM (ed) American society of clinical oncology educational book. ASCO, Alexandria, pp 129–138
14.
Zurück zum Zitat Holland JC, Jacobsen PB, Riba MB (2000) NCCN fever and neutropenia practice guidelines panel. NCCN: distress management. Cancer Control 8(6 Suppl 2):88–93 Holland JC, Jacobsen PB, Riba MB (2000) NCCN fever and neutropenia practice guidelines panel. NCCN: distress management. Cancer Control 8(6 Suppl 2):88–93
15.
Zurück zum Zitat Holland JC (1997) Preliminary guidelines for the management of distress. Oncology; NCCN Proceedings, November, 11(11A):109–114 Holland JC (1997) Preliminary guidelines for the management of distress. Oncology; NCCN Proceedings, November, 11(11A):109–114
16.
Zurück zum Zitat Holland JC (1999) Update: NCCN practice guidelines for the management of psychosocial distress. Oncology, NCCN Proceedings, November; 459–507 Holland JC (1999) Update: NCCN practice guidelines for the management of psychosocial distress. Oncology, NCCN Proceedings, November; 459–507
17.
Zurück zum Zitat Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC (1998) Rapid screening for psychological distress in men with prostate carcinoma. Cancer 82:1904–1908CrossRefPubMed Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC (1998) Rapid screening for psychological distress in men with prostate carcinoma. Cancer 82:1904–1908CrossRefPubMed
18.
Zurück zum Zitat Jacobsen P, Donovan K, Holland JC, Trask P, Fleishman S, Zabora J, Baker F (2004) Multicenter study of the utility of the distress thermometer as a screening instrument in a general cancer population. Psychooncology 13(Suppl 13):42–43 Jacobsen P, Donovan K, Holland JC, Trask P, Fleishman S, Zabora J, Baker F (2004) Multicenter study of the utility of the distress thermometer as a screening instrument in a general cancer population. Psychooncology 13(Suppl 13):42–43
19.
Zurück zum Zitat Donovan KA, Jacobsen P, Holland JC, Trask PC, Fleishman S, Zabora J, Baker F (2004) Psychometric properties and correlates of distress thermometer scale. Psychooncology 13(Suppl 13):16 Donovan KA, Jacobsen P, Holland JC, Trask PC, Fleishman S, Zabora J, Baker F (2004) Psychometric properties and correlates of distress thermometer scale. Psychooncology 13(Suppl 13):16
20.
Zurück zum Zitat Akizuki N, Akechi T, Nakanishi T, Yoshikawa E, Okamura M, Nakano T, Murakami Y, Uchitomi Y (2003) Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer 97:2605–2613 Akizuki N, Akechi T, Nakanishi T, Yoshikawa E, Okamura M, Nakano T, Murakami Y, Uchitomi Y (2003) Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer 97:2605–2613
21.
Zurück zum Zitat Patrick-Miller LJ, Broccoli TL, Levine E, Much JK (2004) Screening for psychosocial distress among ambulatory oncology patients: evaluation of the distress thermometer. Psychooncology 13:S64–S65 Patrick-Miller LJ, Broccoli TL, Levine E, Much JK (2004) Screening for psychosocial distress among ambulatory oncology patients: evaluation of the distress thermometer. Psychooncology 13:S64–S65
22.
Zurück zum Zitat Muszbek K, Balogh M, Molnár M, Rohánszky M, Varga K (2004) Screening for distress of Hungarian cancer patients: validation study of Hungarian version of HADS. Psychooncology 13:S63 Muszbek K, Balogh M, Molnár M, Rohánszky M, Varga K (2004) Screening for distress of Hungarian cancer patients: validation study of Hungarian version of HADS. Psychooncology 13:S63
23.
Zurück zum Zitat Grassi L, Rosti G (1996) Psychiatric and psychosocial concomitants of abnormal illness behaviour in patients with cancer. Psychother Psychosom 65:246–252 Grassi L, Rosti G (1996) Psychiatric and psychosocial concomitants of abnormal illness behaviour in patients with cancer. Psychother Psychosom 65:246–252
24.
Zurück zum Zitat Gil F, Mendez I, Sirgo A, Llort G, Blanco I, Cortes-Funes H (2003) Perception of breast cancer risk and surveillance behaviours of women with family history of breast cancer: a brief report on a Spanish cohort. Psychooncology 12:821–827 Gil F, Mendez I, Sirgo A, Llort G, Blanco I, Cortes-Funes H (2003) Perception of breast cancer risk and surveillance behaviours of women with family history of breast cancer: a brief report on a Spanish cohort. Psychooncology 12:821–827
25.
Zurück zum Zitat Holland J, Sepulveda C, Zabora J, Katib J, Grassi L, Aikizuki N, Carlsson L (2004) Psychosocial distress—the 6th vital sign: from identification to intervention. Psychooncology 13:S56 Holland J, Sepulveda C, Zabora J, Katib J, Grassi L, Aikizuki N, Carlsson L (2004) Psychosocial distress—the 6th vital sign: from identification to intervention. Psychooncology 13:S56
26.
Zurück zum Zitat Grassi L, Travado L, Gil F, Sabato S, Rossi E, SEPOS Group (2004) Psychosocial morbidity and its correlates in cancer patients of the Mediterranean area: findings from the Southern European Psycho-Oncology Study. J Affect Dis 83:243–248 Grassi L, Travado L, Gil F, Sabato S, Rossi E, SEPOS Group (2004) Psychosocial morbidity and its correlates in cancer patients of the Mediterranean area: findings from the Southern European Psycho-Oncology Study. J Affect Dis 83:243–248
27.
Zurück zum Zitat Travado L, Grassi L, Gil F, Ventura C, Martins C, SEPOS Group (in press) Physician–patient communication among Southern European cancer physicians: the influence of psychosocial orientation and burnout. Psychooncology Travado L, Grassi L, Gil F, Ventura C, Martins C, SEPOS Group (in press) Physician–patient communication among Southern European cancer physicians: the influence of psychosocial orientation and burnout. Psychooncology
28.
Zurück zum Zitat Grassi L, Travado L, Gil F, Campos R, Lluch P, Baile W (in press) A communication intervention for training Southern European oncologists to recognize psychosocial morbidity in cancer. I—Development of the model and preliminary results on physicians’ satisfaction. J Cancer Educ Grassi L, Travado L, Gil F, Campos R, Lluch P, Baile W (in press) A communication intervention for training Southern European oncologists to recognize psychosocial morbidity in cancer. I—Development of the model and preliminary results on physicians’ satisfaction. J Cancer Educ
29.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed
30.
Zurück zum Zitat Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191–205 Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191–205
31.
Zurück zum Zitat Lynch ME(1995) The assessment and prevalence of affective disorders in advanced cancer patients. J Palliat Care 11:10–18 Lynch ME(1995) The assessment and prevalence of affective disorders in advanced cancer patients. J Palliat Care 11:10–18
32.
Zurück zum Zitat Zigmond SA, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMed Zigmond SA, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMed
33.
Zurück zum Zitat Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L (1994) Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 30:37–40 Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L (1994) Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 30:37–40
34.
Zurück zum Zitat Razavi D, Delvaux N, Farvacques C, Robaye E, (1990) Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiatry 156:79–83PubMed Razavi D, Delvaux N, Farvacques C, Robaye E, (1990) Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiatry 156:79–83PubMed
35.
Zurück zum Zitat Zweig MH, Campbell G (1993) Receiver-operating characteristics (ROC) plots: a fundamental evaluation in clinical medicine. Clin Chem 39:561–577PubMed Zweig MH, Campbell G (1993) Receiver-operating characteristics (ROC) plots: a fundamental evaluation in clinical medicine. Clin Chem 39:561–577PubMed
36.
Zurück zum Zitat Grassi L, Biancosino B, Sabato S, Marmai L, Rossi E, Gil F, Travado L Screening psychiatric morbidity among cancer patients: Italian data from the Southern European Psycho-Oncology Study (SEPOS) (submitted for publication) Grassi L, Biancosino B, Sabato S, Marmai L, Rossi E, Gil F, Travado L Screening psychiatric morbidity among cancer patients: Italian data from the Southern European Psycho-Oncology Study (SEPOS) (submitted for publication)
37.
Zurück zum Zitat Galeazzi GM, Ferrari S, Mackinnon A, Rigatelli M (2004) Interrater reliability, prevalence, and relation to ICD-10 diagnoses of the diagnostic criteria for psychosomatic research in consultation-liaison psychiatry patients. Psychosomatics 45:386–393 Galeazzi GM, Ferrari S, Mackinnon A, Rigatelli M (2004) Interrater reliability, prevalence, and relation to ICD-10 diagnoses of the diagnostic criteria for psychosomatic research in consultation-liaison psychiatry patients. Psychosomatics 45:386–393
38.
Zurück zum Zitat Grassi L, Sabato S, Rossi E, Biancosino B, Marmai L (in press) The use of the diagnostic criteria for psychosomatic research (DCPR) in oncology. Psychother Psychosom Grassi L, Sabato S, Rossi E, Biancosino B, Marmai L (in press) The use of the diagnostic criteria for psychosomatic research (DCPR) in oncology. Psychother Psychosom
39.
Zurück zum Zitat Chochinov HM, Wilson KG, Enns M, Lander S (1997)“Are you depressed?” Screening for depression in the terminally ill. Am J Psychiatry 154:674–676PubMed Chochinov HM, Wilson KG, Enns M, Lander S (1997)“Are you depressed?” Screening for depression in the terminally ill. Am J Psychiatry 154:674–676PubMed
Metadaten
Titel
Use of distress and depression thermometers to measure psychosocial morbidity among southern European cancer patients
verfasst von
Francisco Gil
Luigi Grassi
Luzia Travado
Michele Tomamichel
Juan Ramón Gonzalez
The SEPOS Group
Publikationsdatum
01.08.2005
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2005
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-005-0780-0

Weitere Artikel der Ausgabe 8/2005

Supportive Care in Cancer 8/2005 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.